Lupus causes your immune system to attack your own healthy tissues, triggering inflammation and damage across multiple organs. The disease can affect your kidneys, skin, heart, joints, and brain, sometimes all at once and sometimes in unpredictable waves. An estimated 204,000 people in the United States have systemic lupus erythematosus (SLE), the most common form, and about 9 out of 10 are women.
How Lupus Turns the Immune System Against Itself
In a healthy immune system, antibodies target foreign invaders like bacteria and viruses. In lupus, the immune system produces autoantibodies that instead latch onto your own cells, specifically targeting the DNA and proteins found inside cell nuclei. These autoantibodies bind to fragments of your own genetic material, forming clumps called immune complexes. Those clumps then settle into tissues throughout the body and trigger an intense inflammatory response.
Once immune complexes lodge in an organ, they activate complement proteins (part of the body’s alarm system) and recruit white blood cells called neutrophils. Those neutrophils release web-like structures meant to trap invaders, but in lupus they damage the lining of blood vessels and surrounding tissue instead. This process also switches on a powerful inflammatory signal, the type 1 interferon response, which further revs up the immune attack. Because the targets of this autoimmune response are molecules found in virtually every cell, the inflammation can show up almost anywhere.
Kidney Damage
The kidneys are one of the most common and serious targets. Up to half of adults with lupus develop kidney disease, and the rate is even higher in children: roughly 8 out of 10. The damage happens when immune complexes deposit in the tiny filtering units of the kidneys, sparking inflammation that impairs their ability to clean waste from the blood.
Early kidney involvement often produces no obvious symptoms. The first signs typically show up on lab work: excess protein spilling into the urine or red blood cells appearing where they shouldn’t. As the damage progresses, you may notice foamy urine, swelling in your legs, feet, ankles, or face, and rising blood pressure. A kidney biopsy is often used to determine how far the disease has progressed and guide treatment decisions. Without control of the underlying inflammation, lupus nephritis can advance to end-stage kidney disease requiring dialysis or transplant.
Skin and Sun Sensitivity
Skin involvement is often the most visible sign of lupus. The hallmark is the butterfly (malar) rash, a red, flat or slightly raised patch that spreads across both cheeks and the bridge of the nose. It can appear suddenly during a flare and fade when inflammation subsides.
A second common skin pattern is discoid lupus, which produces thick, scaly, coin-shaped patches most often on the face and scalp. These lesions don’t typically itch or hurt, but they can leave permanent scarring and discoloration, either lighter or darker than your natural skin tone. On the scalp, discoid lesions can cause hair loss that may be permanent if scarring occurs.
Up to 80 percent of people with lupus find that sunlight triggers or worsens their symptoms. UV light doesn’t just cause a rash locally. Research from Dartmouth has shown that a single exposure to UV light on the skin can set off inflammatory and injury processes in the kidneys as well. In that study, a subset of neutrophils traveled first to the sun-exposed skin and then migrated to the kidneys, carrying the inflammatory response with them. This helps explain why a day in the sun can trigger a full-body flare, not just a skin reaction.
Heart and Blood Vessels
Lupus significantly raises the risk of cardiovascular disease through two overlapping pathways: chronic inflammation of blood vessel walls (vasculitis) and accelerated buildup of fatty plaques in the arteries (atherosclerosis). Autopsy studies have found both processes occurring simultaneously in the coronary arteries of lupus patients. Pericarditis, inflammation of the thin sac surrounding the heart, is one of the more common cardiac complications and can cause sharp chest pain that worsens with deep breathing.
Over time, the persistent inflammation characteristic of lupus speeds up arterial damage that would normally take decades. Cardiovascular disease is now the leading cause of death in people with lupus in Western countries, surpassing infections, which were historically the primary threat. Five-year survival for lupus patients overall is around 91 percent and eight-year survival about 89 percent, but heart and vascular complications remain the biggest long-term risk.
Joints and Muscles
Joint pain and swelling are among the earliest and most common symptoms, affecting the majority of people with lupus at some point. Lupus arthritis typically causes pain and stiffness in the small joints of the hands, wrists, and knees, often on both sides of the body at the same time. Unlike rheumatoid arthritis, lupus-related joint inflammation does not usually erode bone in the early stages. The pain tends to flare alongside other lupus symptoms and improve when the disease is controlled.
That said, years of poorly controlled inflammation can eventually cause structural joint damage. This means that even between flares, some people develop persistent joint problems. The distinction matters because managing lupus inflammation early can help prevent the kind of cumulative damage that leads to chronic joint issues.
Brain and Nervous System
Roughly one-third to one-half of lupus patients experience neurological or neuropsychiatric symptoms at some point. The most common include cognitive impairment (often called “lupus fog”), depression, anxiety, and in more severe cases, seizures. Lupus fog can make it hard to concentrate, remember words, or follow a conversation, and it’s one of the symptoms patients report as most disruptive to daily life.
These neuropsychiatric symptoms carry real consequences beyond quality of life. Studies have found that lupus patients who develop neurological involvement have higher mortality rates than those without it. The mechanism involves the same immune-complex-driven inflammation seen elsewhere in the body, this time targeting blood vessels and tissues in the brain and nervous system.
What Triggers Flares
Lupus is unpredictable, cycling between periods of relative quiet and sudden flares where symptoms intensify. Sunlight is the best-documented trigger, capable of sparking both skin and systemic inflammation in a large majority of patients. Other common triggers include physical or emotional stress, infections, and hormonal shifts, which may partly explain why lupus disproportionately affects women of reproductive age.
Flares vary widely from person to person. For some, a flare means a few days of fatigue and joint pain. For others, it can mean sudden kidney inflammation or a dramatic rash. Tracking personal patterns, such as noting whether flares follow sun exposure, illness, or high-stress periods, helps many people anticipate and manage symptoms before they escalate.
Long-Term Outlook
Survival rates for lupus have improved dramatically over the past several decades. Current data show five-year survival around 91 percent and eight-year survival around 89 percent. The shift in what drives mortality tells the story of that progress: infections used to be the primary killer, but better management of acute disease has made cardiovascular complications and cancer the leading causes of death in lupus patients today.
This means that long-term management of lupus is not only about controlling flares. It also involves addressing the cardiovascular risk that accumulates from years of chronic inflammation. Controlling blood pressure, monitoring kidney function, protecting skin from UV exposure, and staying alert to new or worsening neurological symptoms are all part of living with a disease that can quietly affect multiple organ systems at once.